Table 1.
shows clinicopathologic details on 11 IUP and 11 UP cases included in the study.
| Case | Histology | Sex | Age (Years) | Matched Normal | Estimated Tumor Purity (%) | Target Mean Coverage IMPACT Assay | VAF of Driver Alterations (%) |
|---|---|---|---|---|---|---|---|
| IUP 1 | Inverted Papilloma | Male | 69 | No | 60 | 481 | 19 |
| IUP 2 | Inverted Papilloma | Male | 77 | No | 75 | 501 | 45 |
| IUP 3 | Inverted Papilloma | Female | 66 | No | 80 | 613 | 45 |
| IUP 4 | Inverted Papilloma | Male | 57 | No | 80 | 677 | 46 |
| IUP 5 | Inverted Papilloma | Female | 60 | No | 85 | 539 | 47 |
| *IUP 6 | Inverted Papilloma | Male | 61 | Yes | 80 | 575 | 41 |
| IUP 7 | Inverted Papilloma | Male | 66 | No | 80 | 594 | 43 |
| IUP 8 | Inverted Papilloma | Male | 90 | Yes | 75 | 572 | 41 |
| *IUP 9 | Inverted Papilloma | Male | 53 | Yes | 80 | 579 | 41 |
| *IUP 10 | Inverted Papilloma | Male | 65 | Yes | 70 | 459 | 36 |
| IUP 11 | Inverted Papilloma | Male | 86 | No | 80 | 690 | 56 |
| UP 1 | Papilloma | Male | 70 | No | 85 | 600 | 51 |
| UP 2 | Papilloma | Male | 54 | No | 80 | 711 | 59 |
| UP 3 | Papilloma | Female | 81 | No | 80 | 405 | 59 |
| *UP 4 | Papilloma | Female | 51 | Yes | 50 | 570 | 16 |
| UP 5 | Papilloma | Male | 69 | Yes | 70 | 667 | 54 |
| UP 6 | Papilloma | Male | 65 | Yes | 20 | 409 | 3 |
| *UP 7 | Papilloma | Male | 71 | Yes | 60 | 579 | 31 |
| UP 8 | Papilloma | Female | 31 | No | 70 | 597 | 39 |
| UP 9 | Papilloma | Female | 62 | Yes | 70 | 671 | 25 |
| *UP 10 | Papilloma | Male | 51 | Yes | 50 | 875 | 22 |
| UP 11 | Papilloma | Male | 66 | Yes | 60 | 518 | 33 |
*
Cases that underwent WES also